OCDX - Ortho Clinical is on the rise after winning DOD contract worth over $53 million

Department of Defense (“DOD”) has awarded a $53.7M contract to Ortho Clinical Diagnostics ([[OCDX]] +2.2%) for COVID-19 tests.The agreement made in coordination with the Department of Health and Human Services (“HHS”) relates to COVID-19 antigen and antibody test kits and associated VITROS Systems test analyzers, a statement from the government agency said.Per the contract, Ortho Clinical will be able to expand the monthly production capacity at Rochester, New York facility to 1.8M to 6.7M tests and 25 test analyzers by April 2022.

For further details see:

Ortho Clinical is on the rise after winning DOD contract worth over $53 million